India and Japan will intensify their joint cooperation for the development of a world-class medical device regulatory ecosystem in India, which will facilitate and expedite building up of a world-class medical device industry in India. This was the broad outcome of the 2nd Japan-India Medical Products Regulation Symposium held at Nihonbashi Life Science Building, Tokyo, recently.
We are extremely happy the way cooperation between a global leader in medical devices and an aspiring leader in this sector progressed during the conference. We will see benefits of these deliberations in coming months which will help Indian medical device sector become globally competitive while we will also see increased investment by Japanese investors in Make in India programme, said Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD).
Nath was one of the invitees to this high profile conference and made a presentation on Indian Industry preparedness for the medical devices rules and changing ecosystem for enabling manufacturing in India.
Mr Nath also added that increased cooperation between India and Japan in medical device sector will also help capacity building on export front and increased capability to take on imports, especially from some neighbouring destinations who primarily play on price quotient.
Top government and industry representatives attending the symposium from both the counties deliberated on ways to enhance cooperation in medical device and pharma sector.
The host of the daylong conference was Ministry of Health, Labour and Welfare, Government of Japan and Japanese Pharmaceutical and Medical Device Agency. It was supported by Japan Pharmaceutical Manufacturers Association, Japan Federation of Medical Devices Association, Federation of Pharmaceutical Manufacturers Associations of JAPAN and Osaka Pharmaceutical Manufacturers Association.
The Indian side was represented by topmost officials from Ministry of Health, Family and Welfare, Central Drugs Standard Control Organisation, members from Ficci, Pharmexcil AiMeD and top representatives from Indian medical device industry.
Deliberations took place on important topics such as development of medical device regulation, third party medical certifications system, quality standards and GMP system in countries, strategies and challenges for global drug development, among others.